Anti-Monkeypox virus/MPXV M1R Detect Nanobody(B002)

Référence APR11114-10

Conditionnement : 10mg

Marque : Abcepta

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Anti-Monkeypox virus/MPXV M1R Detect nanobody(B002)

Antibody pairs 4-Detect antibody

 
  •  - Anti-Monkeypox virus/MPXV M1R Detect nanobody(B002) APR11114

    Anti-Monkeypox virus/MPXV M1R Detect nanobody(B002)on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

  •  - Anti-Monkeypox virus/MPXV M1R Detect nanobody(B002) APR11114

    Immobilized Monkeypox Virus M1R, His Tag at 2 ug/mL can bind Anti-Monkeypox virus/MPXV M1R Detect nanobody (B002), EC50=0.008817 ug/mL.

Anti-Monkeypox virus/MPXV M1R Detect nanobody(B002)on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

Product Information

Application
  • Applications Legend:
  • WB=Western Blot
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin-embedded Sections)
  • IHC-F=Immunohistochemistry (Frozen Sections)
  • IF=Immunofluorescence
  • FC=Flow Cytopmetry
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • E=ELISA
  • IP=Immunoprecipitation
  • DB=Dot Blot
  • CHIP=Chromatin Immunoprecipitation
  • FA=Fluorescence Assay
  • IEM=Immuno electron microscopy
  • EIA=Enzyme Immunoassay
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Clonality Monoclonal
Isotype VHH

Additional Information

Target/Specificity M1R
Endotoxin <0.001 EU/ µg
Conjugation None
Expression system CHO
Format nanobody
Molecular Weight (kDa) 78.48 kDa
Formulation 0.1 mM Glycine, 0.2 Mm Nacl, (tris), pH 5
Storage -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Research Areas
  • Primary Antibodies
  • Antibody Collections
  • Recombinant Antibodies